TP53 and breast carcinoma: In this investigation, we show that the abrogation of p53 function, a distinctive feature of basal-like breast carcinomas, is functionally associated with the loss of methylation at the IL-6 proximal promoter, a crucial region for IL-6 gene expression [29,31].